Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tianqi Gu

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Sensors (Basel, Switzerland)|November 17, 2020
A Novel Reconstruction Method for Measurement Data Based on MTLS AlgorithmTianqi Gu, Chenjie Hu, Dawei Tang, et al.
Journal of Immunology Research|June 16, 2022
Comprehensive Analysis Identifies PI3K/Akt Pathway Alternations as an Immune-Related Prognostic Biomarker in Colon Adenocarcinoma Patients Receiving Immune Checkpoint Inhibitor TreatmentAnqi Lin, Tianqi Gu, Xigang Hu, et al.
Applied Optics|January 6, 2023
Micro-dimensional oscillation-based optimization for a dielectric metalens in the mid-infraredTianqi Gu, Xiang Gao, Dawei Tang, et al.
International Journal of Cancer|March 9, 2023
Reply to: Comments on "Adverse reactions associated with immune checkpoint inhibitors and bevacizumab: A pharmacovigilance analysis"Tianqi Gu, Anqi Lin, Haitao Wang, et al.
Applied Optics|October 18, 2022
Profile analysis with reconstruction robustness for measurement data subject to outliersTianqi Gu, Cui Xiong, Dawei Tang, et al.
Journal of the Royal Society, Interface|July 25, 2019
The mechanobiology of actin cytoskeletal proteins during cell-cell fusionJing Cong, Bing Fang, Qian Wang, et al.
Frontiers in Immunology|October 4, 2021
TNF-Alpha Pathway Alternation Predicts Survival of Immune Checkpoint Inhibitors in Non-Small Cell Lung CancerAnqi Lin, Hongman Zhang, Hui Meng, et al.
Immunotherapy|August 16, 2023
<i>CACNA1C</i> mutation as a prognosis predictor of immune checkpoint inhibitor in skin cutaneous melanomaYushan Huang, Anqi Lin, Tianqi Gu, et al.
International Journal of Cancer|October 24, 2022
Adverse reactions associated with immune checkpoint inhibitors and bevacizumab: A pharmacovigilance analysisTianqi Gu, Aimin Jiang, Chaozheng Zhou, et al.
Cancer Biomarkers : Section a of Disease Markers|December 3, 2023
Correlation between IL3 signaling pathway-related genes and immune checkpoint inhibitor efficacy in patients with renal cell carcinomaShuang Hou, Tianqi Gu, Ying Shi, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Sensors (Basel, Switzerland)|November 17, 2020
A Novel Reconstruction Method for Measurement Data Based on MTLS AlgorithmTianqi Gu, Chenjie Hu, Dawei Tang, et al.
Journal of Immunology Research|June 16, 2022
Comprehensive Analysis Identifies PI3K/Akt Pathway Alternations as an Immune-Related Prognostic Biomarker in Colon Adenocarcinoma Patients Receiving Immune Checkpoint Inhibitor TreatmentAnqi Lin, Tianqi Gu, Xigang Hu, et al.
Applied Optics|January 6, 2023
Micro-dimensional oscillation-based optimization for a dielectric metalens in the mid-infraredTianqi Gu, Xiang Gao, Dawei Tang, et al.
International Journal of Cancer|March 9, 2023
Reply to: Comments on "Adverse reactions associated with immune checkpoint inhibitors and bevacizumab: A pharmacovigilance analysis"Tianqi Gu, Anqi Lin, Haitao Wang, et al.
Applied Optics|October 18, 2022
Profile analysis with reconstruction robustness for measurement data subject to outliersTianqi Gu, Cui Xiong, Dawei Tang, et al.
Journal of the Royal Society, Interface|July 25, 2019
The mechanobiology of actin cytoskeletal proteins during cell-cell fusionJing Cong, Bing Fang, Qian Wang, et al.
Frontiers in Immunology|October 4, 2021
TNF-Alpha Pathway Alternation Predicts Survival of Immune Checkpoint Inhibitors in Non-Small Cell Lung CancerAnqi Lin, Hongman Zhang, Hui Meng, et al.
Immunotherapy|August 16, 2023
<i>CACNA1C</i> mutation as a prognosis predictor of immune checkpoint inhibitor in skin cutaneous melanomaYushan Huang, Anqi Lin, Tianqi Gu, et al.
International Journal of Cancer|October 24, 2022
Adverse reactions associated with immune checkpoint inhibitors and bevacizumab: A pharmacovigilance analysisTianqi Gu, Aimin Jiang, Chaozheng Zhou, et al.
Cancer Biomarkers : Section a of Disease Markers|December 3, 2023
Correlation between IL3 signaling pathway-related genes and immune checkpoint inhibitor efficacy in patients with renal cell carcinomaShuang Hou, Tianqi Gu, Ying Shi, et al.
Pageof 2